Entering the U.S. Market for European Pharma: Essential IP and Regulatory Considerations

June 23, 2020 | | Webinar

Webinar Replay

About the Program

This webinar will provide insight on leveraging European data and regulatory approvals to obtain marketing clearance for generic drugs from the U.S. Food and Drug Administration; analyzing the IP landscape to identify potential pipeline products; and establishing strategies for identifying products with market potential. Our presenters will share their perspectives for companies looking to successfully cross the pond and embark on new territory.

Presenters

• Frederick (Rick) Ball, Partner and Team Lead, Life Sciences and Medical Technologies Industry Group, Duane Morris LLP
• Adrian Bradley, Partner, Cleveland Scott York
• Thomas J. Kowalski, Partner, Duane Morris LLP
• Deborah L. Lu, Ph.D., Partner, Duane Morris LLP

About Duane Morris

Duane Morris LLP, a law firm with more than 800 attorneys in offices across the United States and internationally, is asked by a broad array of clients to provide innovative solutions to today’s legal and business challenges.

About Cleveland Scott York

Cleveland Scott York, a European international property firm with offices in London, Hertfordshire, the Thames Valley and Brussels, assists clients with patents, trademarks and design rights to protect and commercialise investments in creativity.